While a first test case in NSW rejected insurers’ interpretation of infectious disease exclusions in COVID-19 business interruption policies, potentially putting the industry on the hook for billions of dollars in claims, QBE says the law is on its side in Victoria.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.
Insurance giant Lloyd’s has rejected what it calls an “incomprehensible” class action pleading by Australian businesses that argue its business interruption policies should have indemnified them for losses stemming from COVID-19 lockdowns.
Botox maker Allergan has successfully challenged a Federal Court judgment dismissing its trade mark lawsuit against an Australian company selling topical creams as an alternative to Botox injections.
Lockdown orders by the Victorian government and an international travel ban in place last year during the first wave of COVID-19 did not trigger a business interruption clause in an IAG policy at the centre of a test case brought by insurers, a judge heard Monday.
A judge has ordered the ACCC to pay the State of NSW’s costs in its failed proceeding against NSW Ports, finding that even though the consumer watchdog did not initially sue the state government that it was a “necessary and proper” party to the case.
A former University of Sydney political economy lecturer who was fired for conduct that included showing students a slide of a Nazi swastika superimposed on the Israeli flag has won a challenge to a ruling tossing his unlawful termination case.
Liberal MP Christian Porter has won his bid to block Nine and News Corp from using secret portions of ABC’s defence to his defamation allegations that the media giants accessed as intervenors in the former Attorney-General’s case.
Law firm Norton Rose Fulbright has rejected findings of dishonesty, deceit and abuse of process in seeking to overturn a $160,000 judgment against it, saying it had no “evil intent” in litigating a long-running dispute with former partner Thomas Martin.
A former Norton Rose Fulbright partner locked in a six-year legal battle with the firm has urged the Full Court to allow a $160,000 damages award in his favour to be recalculated, saying it did not provide enough “sting”, amounting to just $1,500 per partner.